AGREEMENT AND PLAN OF MERGER BY AND AMONG LUMASENSE TECHNOLOGIES, INC., RED ACQUISITION CORPORATION AND MIKRON INFRARED, INC. DATED AS OF FEBRUARY 8, 2007Agreement and Plan of Merger • February 13th, 2007 • Mikron Infrared Inc • Industrial instruments for measurement, display, and control • Delaware
Contract Type FiledFebruary 13th, 2007 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of February 8, 2007, is by and among LumaSense Technologies, Inc., a Delaware corporation (the “Buyer”), Red Acquisition Corporation, a New Jersey corporation and a wholly-owned subsidiary of the Buyer (the “Buyer Subsidiary”), and Mikron Infrared, Inc., a New Jersey corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER BY AND AMONG LUMASENSE TECHNOLOGIES, INC., RED ACQUISITION CORPORATION AND MIKRON INFRARED, INC. DATED AS OF FEBRUARY 8, 2007Agreement and Plan of Merger • February 12th, 2007 • Mikron Infrared Inc • Industrial instruments for measurement, display, and control • Delaware
Contract Type FiledFebruary 12th, 2007 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of February 8, 2007, is by and among LumaSense Technologies, Inc., a Delaware corporation (the “Buyer”), Red Acquisition Corporation, a New Jersey corporation and a wholly-owned subsidiary of the Buyer (the “Buyer Subsidiary”), and Mikron Infrared, Inc., a New Jersey corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER AMONG ST. JUDE MEDICAL, INC. DRAGONFLY MERGER CORP., AND ENDOCARDIAL SOLUTIONS, INC. Dated as of September 23, 2004Agreement and Plan of Merger • September 28th, 2004 • Endocardial Solutions Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledSeptember 28th, 2004 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated as of September 23, 2004 (this “Agreement”), is among St. Jude Medical, Inc., a Minnesota corporation (“Buyer”), Dragon Merger Corp., a Delaware corporation and a wholly-owned subsidiary of Buyer (“Sub”), and Endocardial Solutions, Inc., a Delaware corporation (the “Company”) (Sub and the Company being hereinafter collectively referred to as the “Constituent Corporations”).